TY - JOUR
T1 - The conundrum of COVID-19 treatment targets
T2 - The close correlation with rheumatology. Response to: Ͽ Management of rheumatic diseases in the time of covid-19 pandemic: Perspectives of rheumatology pracitioners from India' by Gupta et al and Antirheumatic agents in covid-19: Is IL-6 the right target?' by Capeechi et al
AU - Monti, Sara
AU - Montecucco, Carlomaurizio
PY - 2020/1/1
Y1 - 2020/1/1
KW - arthritis, rheumatoid
KW - immune system diseases
KW - inflammation
UR - http://www.scopus.com/inward/record.url?scp=85085097425&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85085097425&partnerID=8YFLogxK
U2 - 10.1136/annrheumdis-2020-217545
DO - 10.1136/annrheumdis-2020-217545
M3 - Letter
AN - SCOPUS:85085097425
JO - Annals of the Rheumatic Diseases
JF - Annals of the Rheumatic Diseases
SN - 0003-4967
ER -